Looking back on data analytics stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Palantir Technologies (NASDAQ: PLTR) and its peers.
Organizations generate a lot of data that is stored in silos, often in incompatible formats, making it slow and costly to extract actionable insights, which in turn drives demand for modern cloud-based data analysis platforms that can efficiently analyze the siloed data.
The 7 data analytics stocks we track reported a satisfactory Q1. As a group, revenues beat analysts’ consensus estimates by 2.7% while next quarter’s revenue guidance was 2.6% above.
While some data analytics stocks have fared somewhat better than others, they have collectively declined. On average, share prices are down 4.7% since the latest earnings results.
Best Q1: Palantir Technologies (NASDAQ: PLTR)
Named after the all-seeing stones in "Lord of the Rings," Palantir Technologies (NASDAQ: PLTR) develops software platforms that help government agencies and enterprises integrate, analyze, and operationalize their data for decision-making.
Palantir Technologies reported revenues of $1.63 billion, up 84.7% year on year. This print exceeded analysts’ expectations by 6.1%. Overall, it was a stunning quarter for the company with an impressive beat of analysts’ billings and EBITDA estimates.
Palantir Technologies scored the biggest analyst estimate beat, highest guidance raise, and fastest revenue growth of the whole group. Investor expectations, however, were likely higher than Wall Street’s published projections, leaving some wishing for even better results (analysts’ consensus estimates are those published by big banks and advisory firms, not the investors who make buy and sell decisions). The stock is down 19.7% since reporting and currently trades at $117.33.
CLEAR Secure (NYSE: YOU)
Recognized by its signature blue lanes and biometric pods at airport checkpoints across America, CLEAR Secure (NYSE: YOU) provides biometric identity verification technology that allows subscribers to bypass regular security lines at airports and access secure experiences at various venues.
CLEAR Secure reported revenues of $253 million, up 19.7% year on year, outperforming analysts’ expectations by 3.5%. The business had an exceptional quarter with a solid beat of analysts’ EBITDA estimates and revenue guidance for next quarter exceeding analysts’ expectations.
Although it had a fine quarter compared to its peers, the market seems unhappy with the results as the stock is down 3.4% since reporting. It currently trades at $56.75.
Is now the time to buy CLEAR Secure? Access our full analysis of the earnings results here, it’s free.
Weakest Q1: Domo (NASDAQ: DOMO)
Named for the Japanese word meaning "thank you very much," Domo (NASDAQ: DOMO) provides a cloud-based business intelligence platform that connects people with real-time data and insights across organizations.
Domo reported revenues of $79.4 million, flat year on year, falling short of analysts’ expectations by 0.6%. It was a disappointing quarter as it posted a significant miss of analysts’ billings estimates.
Domo delivered the weakest performance against analyst estimates in the group. Interestingly, the stock is up 3.5% since the results and currently trades at $3.07.
Read our full analysis of Domo’s results here.
Health Catalyst (NASDAQ: HCAT)
Built on its "Health Catalyst Flywheel" methodology that emphasizes measurable outcomes, Health Catalyst (NASDAQ: HCAT) provides data and analytics technology and services that help healthcare organizations manage their data and drive measurable clinical, financial, and operational improvements.
Health Catalyst reported revenues of $70.76 million, down 10.9% year on year. This print topped analysts’ expectations by 2.3%. Taking a step back, it was a slower quarter as it logged full-year EBITDA guidance missing analysts’ expectations significantly and revenue guidance for next quarter missing analysts’ expectations.
Health Catalyst had the weakest guidance update, slowest revenue growth, and weakest full-year guidance update among its peers. The stock is up 44.2% since reporting and currently trades at $1.99.
Read our full, actionable report on Health Catalyst here, it’s free.
Strategy (NASDAQ: MSTR)
Once a traditional business intelligence software provider, Strategy (NASDAQ: MSTR) develops AI-powered enterprise analytics software while also functioning as a major corporate holder of Bitcoin cryptocurrency.
Strategy reported revenues of $124.3 million, up 11.9% year on year. This result beat analysts’ expectations by 2%. Zooming out, it was a softer quarter as it produced a significant miss of analysts’ billings estimates.
The stock is down 53.8% since reporting and currently trades at $86.33.
Read our full, actionable report on Strategy here, it’s free.
Market Update
Late in 2025 into early 2026, there was hand-wringing around artificial intelligence. For software companies, the fear was that AI would erode pricing power and compress margins as new tools made it easier to replicate what once required expensive enterprise platforms. Crypto investors had their own version of the same anxiety: if AI agents could trade, allocate capital, and manage wallets autonomously, what exactly was the long-term value of today’s crypto infrastructure?
These concerns triggered a noticeable rotation away from these sectors and into safer havens. But markets rarely dwell on one narrative for long. Spring 2026 came, and the focus shifted abruptly from technological disruption to geopolitical risk. The US’ conflict with Iran became the dominant driver of market psychology, and when geopolitics takes center stage, the script changes quickly. Investors stop debating growth rates and start worrying about oil supply, inflation, and global stability.
Want to invest in winners with rock-solid fundamentals? Check out our Top 5 Quality Compounder Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.
